Immunohistochemical Mucin Expression of Short-Segment Barrett's Esophagus

Tokai Journal of Experimental and Clinical Medicine

Volumn 28, Issue 2, 2003, Pages 57-63

  Yamamoto, Soichiro ^a   Kijima, Hiroshi ^a   Hara, Tadashi ^a   Kenmochi, Takahiro ^a   Kise, Yoshifumi ^a   Tanaka, Hikaru ^a   Chino, Osamu ^a   Shimada, Hideo ^a   Tanaka, Makiko ^a   Inokuchi, Sadaki ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Barrett's mucosa; Esophagus; Immunohistochemistry; Ki 67; Mucin

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; KI 67 ANTIGEN; MUCIN; MUCIN 2; MUCIN 5AC; MUCIN 6;

ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; INTESTINE METAPLASIA; LABELING INDEX; PRECANCER;

BARRETT ESOPHAGUS; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; KI-67 ANTIGEN; METAPLASIA; MUCINS; NEPRILYSIN; STAINING AND LABELING;

EID: 0348231986     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK.: The histologic spectrum of Barrett's esophagus. N Engl J Med 295: 476-480, 1976
2. Nishimaki T, Holscher AH, Schuler M, Becker K, Muto T, Siewert JR.: Chronic esophagitis and subsequent morphological changes of the esophageal mucosa in Barrett's esophagus: a histological study ofesophagectomy specimens. Surg Today 24: 203-209, 1994
3. Spechler SJ.: Short and ultrashort Barrett's esophagus-what does it mean? Semin Gastrointest Dis 8: 59-67, 1997
4. Nakamura M, Kawano T, Endo M, Iwai T.: Intestinal metaplasia at the esophagogastric junction in Japanese patients without clinical Barrett's esophagus. Am J Gastroenterol 94: 3145-3149, 1999
5. Dekker J, Rossen JW, Buller HA, Einerhand AW.: The MUC family: an obituary. Trends Biochem Sci 27: 126-131, 2002
6. Wittel UA, Goel A, Varshney GC, Batra SK.: Mucin antibodies - new tools in diagnosis and therapy of cancer. Front Biosci 6: D1296-1310, 2001
7. Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK.: Structural organization and classification of the human mucin genes. Front Biosci 6: D1192-1206, 2001
8. Fowler J, Vinall L, Swallow D.: Polymorphism of the human muc genes. Front Biosci 6: D1207-1215, 2001
9. McIntosh GG, Lodge AJ, Watson P, Hall AG, Wood K, Anderson JJ, Angus B, Horne CH, Milton ID.: NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 154: 77-82, 1999
10. Haralambidou S, Melo JV, Catovsky D.: Different reactivity of monoclonal antibodies against common acute lymphoblastic leukaemia antigen (CD10). J Clin Pathol 40: 490-493, 1987
11. Mechtersheimer G, Moller P.: Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors. Am J Pathol 134: 961-965, 1989
12. Ng IO, Na J, Lai EC, Fan ST, Ng M.: Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen. Am J Clin Pathol 104: 313-318, 1995
13. Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, Ono K, Matsumoto K.: Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 63: 1607-1611, 1989
14. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H.: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984
15. Gerdes J, Schwab U, Lemke H, Stein H.: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1983
16. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, Makuuchi H.: MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Oncol Rep 8: 485-489, 2001
17. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Tsukui M, Tanaka Y, Matsubayasi H, Tsuchida T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T, Makuuchi H.: DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion. Int J Oncol 16: 455-459, 2000
18. Kijima H, Chino O, Oshiba G, Tanaka H, Kenmochi T, Kise Y, Shimada H, Abe Y, Tokunaga T, Yamazaki H, Nakamura M, Tanaka M, Makuuchi H, Ueyama Y.: Immunohistochemical MUC1 (DF3 antigen) expression of human esophageal squamous cell carcinoma. Anticancer Res 21: 1285-1289, 2001
19. Matsubayashi H, Kuraoka K, Kobayashi Y, Yokota T, Iiri Y, Shichijo K, Tada T, Satoh K, Kijima H.: Ruptured epidermoid cyst and haematoma of spleen: a diagnostic clue of high levels of serum carcinoembryonic antigen, carbohydrate antigen 19-9 and Sialyl Lewis x. Dig Liver Dis 33: 595-599, 2001
20. Nagata J, Kijima H, Hasumi K, Suzuki T, Shirai T, Mine T.: Adenocarcinoma and multiple adenomas of the large intestine, associated with Cronkhite-Canada syndrome. Dig Liver Dis 35: 434-438, 2003
21. Glickman JN, Chen YY, Wang HH, Antonioli DA, Odze RD.: Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 25: 569-578, 2001
22. van Sandick JW, van Lanschot JB, van Felius L, Haringsma J, Tytgat GN, Dekker W, Drillenburg P, Offerhaus GJ, ten Kate FJ.: Intestinal metaplasia of the esophagus or esophagogastric junction: evidence of distinct clinical, pathologic, and histochemical staining features. Am J Clin Pathol 117: 117-125, 2002
23. Oberg S, Johansson J, Wenner J, Walther B.: Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 235: 338-345, 2002
24. Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP.: Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut 47: 753-761, 2000
25. Guillem P, Billeret V, Buisine MP, Flejou JF, Lecomte-Houcke M, Degand P, Aubert JP, Triboulet JP, Porchet N.: Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 88: 856-861, 2000
26. Warson C, Van De Bovenkamp JH, Korteland-Van Male AM, Buller HA, Einerhand AW, Ectors NL, Dekker J.: Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum Pathol 33: 660-668, 2002
27. Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD.: Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histopathology 35: 517-524, 1999
28. Endo T, Tamaki K, Arimura Y, Itoh F, Hinoda Y, Hareyama M, Irimura T, Fujita M, Imai K.: Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol 33: 811-815, 1998
29. Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M.: Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59: 1003-1007, 1999
30. Inada K, Nakanishi H, Fujimitsu Y, Shimizu N, Ichinose M, Miki K, Nakamura S, Tatematsu M.: Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach. Pathol Int 47: 831-841, 1997
31. Teixeira A, David L, Reis CA, Costa J, Sobrinho-Simoes M.: Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J Pathol 197: 37-43, 2002
32. Allen A, Hutton DA, Pearson JP. The MUC2 gene product: a human intestinal mucin.: Int J Biochem Cell Biol 30: 797-801, 1998
33. Terasaki-Fukuzawa Y, Kijima H, Suto A, Takeshita T, Iezumi K, Sato S, Yoshida H, Sato T, Shimbori M, Shiina Y.: Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma. Int J Mol Med 9: 25-29, 2002